Catalyst Wire Dossier Catalyst Wire Dossier

Oral hPTH(1-34) Tablet (experimental formulation)

human parathyroid hormone (1-34) · Entera Bio Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Oral hPTH(1-34) Tablet (experimental formulation), covering 2026-02-17 to 2026-02-17. Get the full timeline:

Most recent: Clinical Trial Update: Assess Safety and Compare PK of New Oral hPTH(1-34) Tablet Formulations vs. EBP05 Tablets and Subcutaneous Forteo [Phase 1]

See pricing